AzTrials
AzTrials

ObeseHW8YAPilotNCT06943651

Empowering Healthy Lifestyle Behavior to Prevent and Control Obesity in Young Adults

A study testing HealthyW8 Digital Twin of healthy lifestyle recommendations in people with Obese and Overweight, run by University of Évora.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This human study will be a pilot trial that will precede a planned more long-term intervention trial. It will focus on young adults (age 18 to 25 y). The main purpose is to study whether the healthy lifestyle recommender solution, reflecting a multi-portfolio intervention and developed within this project, is well… Read more about this study

Who is it for?
Ages 18 to 25 years
Conditions the study is for
Obese, Overweight
What is being tested?
HealthyW8 Digital Twin of healthy lifestyle recommendations
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
No sites listed yet
Study dates
21 Apr 2025to 31 Jul 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • To be young adult (age 18-25 y)
  • To reside in Portugal
  • To be overweight (BMI between 25-30 kg/m2)
  • Women and men

Who cannot join

  • To have a manifest chronic diseases (e.g. cancer)
  • To be already in energy restriction or following a specific diet (on their own or advised by their physician)
  • To have eating behavior pathologies.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Elsa Lamy, PhD contact

+351266780800

ecsl@uevora.pt

Maria Perez-Jimenez, PhD contact

+351266780800

maria.jimenez@uevora.pt

About this study

Official title: Empowering Healthy Lifestyle Behaviour Through Personalized Intervention Portfolios to Prevent and Control Obesity in Young Adults - A Pilot Study

This human study will be a pilot trial that will precede a planned more long-term intervention trial. It will focus on young adults (age 18 to 25 y). The main purpose is to study whether the healthy lifestyle recommender solution, reflecting a multi-portfolio intervention and developed within this project, is well accepted by the participants, has a decent adherence (i.e. user time of the app), and whether the overall design is well suited to the participants, in order that they will improve dietary habits. This study will be of longitudinal design without a control group.

At present, numbers of persons with overweight and obesity continue to grow in most countries worldwide. Young adults are at risk since in in this period of life most people start to be independent from their families, with the consequent decisions about their food and lifestyle choices. It is frequent that at this time an increase in irregularity of meals and unhealthy food choices, occurs, together with changes in physical activity habits and social or individual pressures. Because of this, it is essential to give tools to these individuals that will allow them to make healthy choices and to have healthy habits, since they will be the future adult population that will raise and inspire the next generation. As solutions to combat the trend toward increasing overweight and obesity are much in need, the present study aims to intervene with the developed healthy lifestyle recommender solution to address various factors known to constitute a risk for developing obesity, including socio-demographic aspects, psychological/behavioural ones, physical activity, dietary patterns, among other. Such a multi-dimensional portfolio approach is believed to be very much needed for the prevention of obesity and co-morbidities, and the personalization of the solution, as well as the nudging/gamification.

Read the detailed description

The applied intervention with the developed healthy lifestyle recommender system will be unique and is not used in any other clinical study. However, a large number of intervention studies on young adults' obesity, considering nudging (e.g. 60 in www.clinical.trials.gov), were found. Among the registered clinical trials in the referred database, 3 considered young adults obesity and saliva salivary analysis.

The investigators judge the risk for the participant as low, since only saliva will be collected which collection is totally non-invasive. The administered intervention is expected to be effective, based on the multi-level nature of the tools applied.

This is a longitudinal study, non-controlled. Participants will receive the developed healthy life-style recommender solution for the duration of the study, and endpoints within subjects will be compared before and after.

The investigators are aware of the potential influence of seasons and other longitudinal changes on the outcomes, however as the endpoints are rather motivation and adherence, the investigators deem the design as appropriate. Moreover, in case of salivary parameters, which can be more sensitive to this type of variation, the collection in three successive days, before and at the end of the trial (to be analysed as pooled samples) will minimize these potential effects.

The intervention is the developed eHealth solution, i.e. the healthy lifestyle recommender system. It is based on a previously developed meal recommender system, but will be much extended, resulting in a multilevel portfolio intervention regarding:

  1. Suggesting personalized meal recommendations,
  2. Proposing physical activities tailored to the individuals' capabilities and preferences,
  3. Measuring and considering emotional and psychological parameters,
  4. Proposing additional healthy life-style patterns regarding e.g. sleeping patterns, alcohol and tobacco consumption, engaging in social activities etc.

The detailed nature of the interventions will first be developed during co-creation and then targeted to the participating individual. The intervention will include collecting urinary and saliva samples, as well as measuring anthropometrics and collecting data (personal, socio-demographics, general health and well-being, physical activity and eating patterns, among other) via questionnaires.

The study duration will be 3 months from the official start to the end. Following a first interview to test participants eligibility, the investigators have compiled a list of exemplary endpoints in the following, providing an overview about the sampling frequency.

Young adults (age 18-25 y) will be recruited via university and local hospital (Hospital do Espirito Santo - Évora), with help from the researchers from the School of Health Sciences, by direct advertisement and by recommendation of Hospital dietitians. The run-in time of the study will be long enough to assure recruitment of the required number of persons. The participants will be followed up regularly by phone-calls from the team of the University of Évora (e.g. weekly), and via contact maintained through the developed healthy lifestyle recommender solution. Should recruitment be insufficient, additional advertisement via local newspapers will be carried out, and the run-in time be extended.

Participants will receive the developed healthy lifestyle recommender solution. The individuals will then make use of the healthy lifestyle recommender solution for the entire study, i.e. a personalized, multi-level portfolio intervention will be tailored to the individual. The details of this intervention, including also nudges and gamification aspects will have to be developed during the project (WPs 2). Weekly phone-calls with participants from both groups will assure further adherence to the study.

Collected samples (month 0 and month 3) will be stored locally at University of Evora. All data and questionnaires will be collected by trained personnel, using RedCap platform. Data will be stored under a protected server, under the responsibility of Luxemburg Institute of Health, which is the leading institution of the project HealthyW8, under which this study is being developed. Individual data will be not linked to participants identification, since each participant will receive a code, at the beginning, answering all questionnaires and collecting all the samples under that identification (code). Only the researcher responsible for the study will have assess to the correspondence between identification and codes. This correspondence will be stored in an external drive, safely stored in the University of Evora and without being connected to internet.

The intervention will only require the healthy lifestyle recommender solution in form of an app. In addition, participants in the intervention arm will be able to access the Open Stakeholders Platform to access further information on healthy living. All data collected will be compiled in clinical report forms that will be generated by the University of Evora team. Saliva will be collected by trained researchers from the University of Evora. Regarding questionnaires, the investigators will use previous developed and validated questionnaires, such as the IPAQ questionnaire for physical activity or the SF-36 questionnaire for healthy lifestyle.

Conditions
Obese, Overweight
Being tested
HealthyW8 Digital Twin of healthy lifestyle recommendations
Keywords
Obesity, Overweight, Digital twin, Obesity prevention, Lifestyle
Medical subject headings
Obesity, Overweight

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HealthyW8 Digital Twin of healthy lifestyle recommendationsDevice

    The applied intervention with the developed healthy lifestyle recommender system will be unique and is not used in any other clinical study. However, a large number of intervention studies on young adults' obesity, considering nudging (e.g. 60 in www.clinical.trials.gov), were found. Among the registered clinical trials in the referred database, 3 considered young adults obesity and saliva salivary analysis, but with a different purpose. Moreover, the type of digital solution that will be tested will put together different aspects that are not usually to see together in the same application. These different lifestyle aspects will be used for personalized recommendations.

Study groups in NCT06943651
Study groupRoleWhat they receive
Test of healthyW8 Digital Twin of healthy lifestyle recommendationsExperimentalIndividuals will have access to a digital tool, putting together nutrition, physical activity and emotional aspects. Participant interaction with the tool, through registration collected or inputed by the individual will allow personalized recommendations.
Receives: Device: HealthyW8 Digital Twin of healthy lifestyle recommendations

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adherence to digital tool

    Adherence time to the lifestyle recommender solution, in order to determine the success of application of the healthy-lifestyle recommender solution to the target population (the young adults).

    Measured: 3-month

  2. Satisfaction relative to the digital solution

    The satisfaction for the use of the digital solution will be assessed through questionnaires addressing the user-friendliness and limitation or problems encountered.

    Scales will be used, where higher scores mean higher satisfaction.

    Measured: 3 months

Secondary outcomes (8)
  1. Anthropometry

    Secondary outcomes (measured at the end of the 3-month period of the pilot):

    Change of BMI, relatively to the beginning of the intervention.

    Measured: 3-month

  2. Fat Mass

    Reduction of fat mass will be determined by measuring body composition through bio impedance at beginning and end of 3-month trial. The difference will allow to assess if fat mass decreased or increased, during this period.

    Measured: 3-months

  3. Blood Pressure

    Blood pressure (systolic, diastolic) will be measured at the beginning and at the end of the 3-month trial.

    Measured: 3-month

  4. Salivary biomarkers

    Saliva composition will be assessed for measuring concentration of C-reactive protein, salivary IgA, glucose and insulin. This will be done at the beginning and at the end of the 3-month trial, to assess changes during this period.

    Measured: 3-month

  5. Salivary markers of stress

    Concentrations of salivary cortisol will be measured at the beginning and at the end of the 3-month period of the trial.

    Measured: 3-month

  6. Salivary Amylase

    The enzymatic activity per unit of saliva volume will be assessed for amylase. This will be done in saliva collected at the beginning and at the end of 3-month trial.

    Measured: 3-month

  7. Physical activity

    The level of physical-activity habits will be assessed using the IPAQ short form. The participants will be assessed at the beginning of the trial.

    Measured: At the beginning of the study

  8. Diet

    The dietary habits will be assessed using a 24h-recall, applied for 3 different days, at the beginning of the trial. The results will allow to estimate the average amount of macro- and micronutrients daily ingested.

    Measured: 1 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Apr 2025
  2. Study start21 Apr 2025 (estimated)
  3. Primary completion20 Jun 2025 (estimated)
  4. Study completion31 Jul 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
This is a longitudinal study, non-controlled. Participants will receive the developed healthy life-style recommender solution for the duration of the study, and endpoints within subjects will be compared before and after.
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06943651
Sponsor's protocol ID
UEVHealthyW8YAdults
Other IDs
GA - 101080645
Acronym
HW8YAPilot
Status last verified
Mar 2025
First submitted
15 Nov 2024
Last updated
24 Apr 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The investigators will follow the General Data Protection Regulation (EU) 2016/679 of 27 April 2016 (known as the GDPR) and all subsequent texts replacing or supplementing this Regulation Before the start of the study, all subjects will be informed about the aim of the study, the study protocol, as well as risks/benefits. Only the researcher responsible for the study will have access to the correspondence between identification and the codes generated. This correspondence will be stored in a computer protected with password, not linked to internet and in a drive, stored in the University of Evora. All data (questionnaires, samples, etc.) will be identified with the participant code and not personal identification. Data will be presented treated, and no individual data, that could allow participant identification, will be public presented.

Questions about this trial

What is this clinical trial studying?

A study testing HealthyW8 Digital Twin of healthy lifestyle recommendations in people with Obese and Overweight, run by University of Évora.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 24 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Elsa Lamy, PhD (+351266780800, ecsl@uevora.pt), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adherence to digital tool (time frame: 3-month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in